1 week ago
Novo Nordisk (NVO) Stock Climbs as Company Launches Trial for Lower-Dose Wegovy Pills
Novo Nordisk (NVO) stock gains as the pharma giant starts a trial testing lower Wegovy doses, with Q2 sales reaching $500M and 5M+ prescriptions filled.
The post Novo Nordisk (NVO) Stock Climbs as Company Launches Trial for Lower-Dose Wegovy Pills appeared first on Blockonomi.
Source: Blockonomi →Related News
- 9 hours ago
The Trade Desk, Inc. (TTD) Stock: New Zuma Platform Brings Smarter AI, Simpler M...
- 9 hours ago
Laser Photonics Corporation (LASE) Stock: SOCOM Engagement Puts Counter-Drone Sy...
- 12 hours ago
Amazon (AMZN) Stock: Expands Nvidia Partnership as AI Demand Grows
- 13 hours ago
Marvell Technology (MRVL) Q2 Earnings Preview: Should Investors Buy Before Thurs...
- 13 hours ago
Nvidia (NVDA), Salesforce (CRM), CrowdStrike (CRWD), and Okta (OKTA) Soar as AI...